NFlection Therapeutics Launches with $20M Series A Funding to Advance Lead Program in Neurofibromatosis June 9, 2020
Innovent and Roche Enter into A Strategic Collaboration to Discover and Develop Multiple Products including Cellular Therapies and Bispecific Antibodies June 9, 2020
Buoy Health Launches Back with CareTM and Forms Advisory Board to Support Safe Return to the Workplace June 8, 2020
Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial of PBCAR269A for Multiple Myeloma June 8, 2020
Affinia Therapeutics Announces Appointment of Elliott Sigal, M.D., Ph.D. to the Company’s Board of Directors June 8, 2020
Innovent Announces the Preliminary Results of the Anti-PD-1/PD-L1 Bispecific Antibody IBI318 in a Phase 1 Clinical Study June 1, 2020